Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GRANULOCYTOPENIC PATIENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 206 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Agaoglu, L; Devecioglu, O; Anak, S; Karakas, Z; Yalman, N; Biner, B; Eryilmaz, E; Goksan, B; Unuvar, A; Agirbasli, H; Can, M; Bilgen, H; Gedikoglu, G
      Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey

      JOURNAL OF CHEMOTHERAPY
    2. Del Favero, A; Menichetti, F; Martino, P; Bucaneve, G; Micozzi, A; Gentile, G; Furno, P; Russo, D; D'Antonio, D; Ricci, P; Martino, B; Mandelli, F
      A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

      CLINICAL INFECTIOUS DISEASES
    3. Collin, BA; Leather, HL; Wingard, JR; Ramphal, R
      Evolution, incidence, and susceptibility of bacterial bloodstream isolatesfrom 519 bone marrow transplant patients

      CLINICAL INFECTIOUS DISEASES
    4. Viscoli, C; Paesmans, M; Sanz, M; Castagnola, E; Klastersky, J; Martino, P; Glauser, M
      Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients

      CLINICAL INFECTIOUS DISEASES
    5. Fleming, RV; Kantarjian, HM; Husni, R; Rolston, K; Lim, J; Raad, I; Pierce, S; Cortes, J; Estey, E
      Comparison of amphotericin B lipid complex (ABLC) vs. AmBisome in the treatment of suspected or documented fungal infections in patients with leukemia

      LEUKEMIA & LYMPHOMA
    6. Ariffin, H; Arasu, A; Mahfuzah, M; Ariffin, WA; Chan, LL; Lin, HP
      Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer

      JOURNAL OF PAEDIATRICS AND CHILD HEALTH
    7. Haupt, R; Romanengo, M; Fears, T; Viscoli, C; Castagnola, E
      Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution

      EUROPEAN JOURNAL OF CANCER
    8. Gonzalez-Barca, E; Carratala, J; Mykietiuk, A; Fernandez-Sevilla, A; Gudiol, F
      Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    9. Leather, HL; Wingard, JR
      Infections following hematopoietic stem cell transplantation

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    10. Simon, A; Fleischhack, G; Marklein, G; Ritter, J
      Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients.

      KLINISCHE PADIATRIE
    11. Zaidi, Y; Hastings, M; Murray, J; Hassan, R; Kurshid, M; Mahendra, P
      Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan

      CLINICAL AND LABORATORY HAEMATOLOGY
    12. Alcaide, F; Benitez, MA; Carratala, J; Gudiol, F; Linares, J; Martin, R
      In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    13. Borbolla, JR; Lopez-Hernandez, MA; Gonzalez-Avante, M; DeDiego, J; Trueba, E; Alvarado, ML; Jimenez, RM
      Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients

      CHEMOTHERAPY
    14. Hann, IM
      Management of infection in children with bone marrow failure

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    15. Gordts, B; Firre, E; Jordens, P; Legrand, JC; Maertens, J; Struelens, M
      National guidelines for the judicious use of glycopeptides in Belgium

      CLINICAL MICROBIOLOGY AND INFECTION
    16. Paladino, JA; Fong, DA; Forrest, A; Ramphal, R
      Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy - For the treatment of febrile episodes in neutropenic patients

      PHARMACOECONOMICS
    17. Chandrasekar, PH; Arnow, PM
      Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer

      ANNALS OF PHARMACOTHERAPY
    18. Marron, A; Carratala, J; Gonzalez-Barca, E; Fernandez-Sevilla, A; Alcaide, F; Gudiol, F
      Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer

      CLINICAL INFECTIOUS DISEASES
    19. Vandercam, B; Gerain, J; Humblet, Y; Ferrant, A; Wauters, G; Moreau, M; Longueville, J; Symann, M; Straetmans, N
      Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

      ANNALS OF HEMATOLOGY
    20. Maschmeyer, G; Braveny, I
      Review of the incidence and prognosis of Pseudomonas aeruginosa infectionsin cancer patients in the 1990s

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    21. Klastersky, J
      Empirical treatment of sepsis in neutropenic patients

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    22. Egerer, G; Goldschmidt, H; Salwender, H; Hegenbart, U; Ehrhard, I; Haas, R; Ho, AD
      Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    23. Bush, LM; Johnson, CC
      Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    24. Thomas, X; Troncy, J; Belhabri, A; Thiebaut, A; Bouheddou, N; Michallet, M; Fleurette, J; Pivot, C; Fiere, D; Archimbaud, E
      A double-blind randomized study evaluating the vancomycin-pefloxacin combination as a gastrointestinal tract decontaminant for the prevention of infections in patients with chemotherapy-induced neutropenia

      PRESSE MEDICALE
    25. Feld, R; DePauw, B; Berman, S; Keating, A; Ho, W
      Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial

      JOURNAL OF CLINICAL ONCOLOGY
    26. Fleischhack, G; Cipic, D; Juettner, J; Hasan, C; Bode, U
      Procalcitonin - a sensitive inflammation marker of febrile episodes in neutropenic children with cancer

      INTENSIVE CARE MEDICINE
    27. Glauser, MP
      Neutropenia: clinical implications and modulation

      INTENSIVE CARE MEDICINE
    28. Erjavec, Z; de Vries-Hospers, HG; Laseur, M; Halie, RM; Daenen, S
      A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy

      Journal of antimicrobial chemotherapy
    29. Delarive, P; Baumgartner, JD; Glauser, MP; Cometta, A
      Evaluation of antibiotic prophylaxis in neutropenic patients with haematological malignancies

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    30. Arber, C; Passweg, JR; Fluckiger, U; Pless, M; Gregor, M; Tichelli, A; Schifferli, JA; Gratwohl, A
      C-reactive protein and fever in neutropenic patients

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    31. Kanda, Y; Yamamoto, R; Chizuka, A; Hamaki, T; Suguro, M; Arai, C; Matsuyama, T; Takezako, N; Miwa, A; Kern, W; Kami, M; Akiyama, H; Hirai, H; Togawa, A
      Prophylactic action of oral fluconazole against fungal infection in neutropenic patients - A meta-analysis of 16 randomized, controlled trials

      CANCER
    32. Fleischhack, G; Kambeck, I; Cipic, D; Hasan, C; Bode, U
      Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II

      BRITISH JOURNAL OF HAEMATOLOGY
    33. Chatzinikolaou, I; Abi-Said, D; Bodey, GP; Rolston, KVI; Tarrand, JJ; Samonis, G
      Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer - Retrospective analysis of 245 episodes

      ARCHIVES OF INTERNAL MEDICINE
    34. Tollemar, J
      Prophylaxis against fungal infections in transplant recipients: Possible approaches

      BIODRUGS
    35. Venditti, M; Martino, P; Viscoli, C; Klastersky, J
      Ceftriaxone alone or in combination with antibiotics in the management of infection in cancer patients - A review of 41 clinical trials involving 7350 patient-episodes

      CLINICAL DRUG INVESTIGATION
    36. Bucaneve, G; Menichetti, F; Del Favero, A
      Cost analysis of 2 empiric antibacterial regimens containing glycopeptidesfor the treatment of febrile neutropenia in patients with acute leukaemia

      PHARMACOECONOMICS
    37. Zinner, SH
      Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria

      CLINICAL INFECTIOUS DISEASES
    38. Ramphal, R
      Is monotherapy for febrile neutropenia still a viable alternative?

      CLINICAL INFECTIOUS DISEASES
    39. Viscoli, C; Castagnola, E; Giacchino, M; Cesaro, S; Properzi, E; Tucci, F; Mura, RM; Alvisi, P; Zanazzo, G; Surico, G; Bonetti, F; De Sio, L; Izzi, G; Di Cataldo, A; Ziino, O; Massolo, F; Nardi, M; Santoro, N; Binda, S
      Bloodstream infections in children with cancer: a multicentre surveillancestudy of the Italian Association of Paediatric Haematology and Oncology

      EUROPEAN JOURNAL OF CANCER
    40. Gonzalez-Barca, E; Fernandez-Sevilla, A; Carratala, J; Salar, A; Peris, J; Granena, A; Gudiol, F
      Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    41. Akova, M; Akan, H; Korten, V; Biberoglu, K; Hayran, M; Unal, S; Kars, A; Kansu, E
      Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    42. Bradley, JS; Garau, J; Lode, H; Rolston, KVI; Wilson, SE; Quinn, JP
      Carbapenems in clinical practice: a guide to their use in serious infection

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    43. Rubenstein, E; Wade, JC
      NCCN practice guidelines for fever and neutropenia

      ONCOLOGY-NEW YORK
    44. Hoffken, G; Pasold, R; Pfluger, KH; Finke, J; Fauser, AA; Szelenyi, H; Wagner, J
      An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients

      Journal of antimicrobial chemotherapy
    45. Schnake, KJ; Sugarbaker, PH; Yoo, D
      Neutropenia following perioperative intraperitoneal chemotherapy

      TUMORI
    46. Barsic, B; Beus, I; Marton, E; Himbele, J; Klinar, I
      Nosocomial infections in critically ill infectious disease patients: Results of a 7-year focal surveillance

      INFECTION
    47. Salazar, R; Sola, C; Maroto, P; Tabernero, JM; Brunet, J; Verger, G; Valenti, V; Cancelas, JA; Ojeda, B; Mendoza, L; Rodriguez, M; Montesinos, J; Lopez-Lopez, JJ
      Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    48. Johansen, HK; Gotzsche, PC
      Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    49. Skladny, H; Buchheidt, D; Baust, C; Krieg-Schneider, F; Seifarth, W; Leib-Mosch, C; Hehlmann, R
      Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR

      JOURNAL OF CLINICAL MICROBIOLOGY
    50. Norrby, SR; Gildon, KM
      Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    51. Wright, AJ
      The penicillins

      MAYO CLINIC PROCEEDINGS
    52. Martin, JN; Rose, DA; Hadley, WK; Perdreau-Remington, F; Lam, PK; Gerberding, JL
      Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era

      JOURNAL OF INFECTIOUS DISEASES
    53. Huijgens, PC; Simoons-Smit, AM; van Loenen, AC; Prooy, E; van Tinteren, H; Ossenkoppele, GJ; Jonkhoff, AR
      Fluconazole versus itraconazole for the prevention of fungal infections inhaemato-oncology

      JOURNAL OF CLINICAL PATHOLOGY
    54. ALEDO A; HELLER G; REN L; GARDNER S; DUNKEL I; MCKAY SW; FLOMBAUM C; BROWN AE
      SEPTICEMIA AND SEPTIC SHOCK IN PEDIATRIC-PATIENTS - 140 CONSECUTIVE CASES ON A PEDIATRIC HEMATOLOGY-ONCOLOGY SERVICE

      Journal of pediatric hematology/oncology
    55. WINGARD JR
      EARLY INTERVENTION IN INVASIVE FUNGAL DISEASE WITH ANTIFUNGAL DRUGS

      Infectious diseases in clinical practice
    56. KIBBLER CC; PRENTICE HG
      A REAPPRAISAL OF CURRENT APPROACHES TO THE MANAGEMENT OF FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS

      Current opinion in infectious diseases
    57. CASTAGNOLA E; PAOLA D; GIACCHINO R; ROSSI R; VISCOLI C
      ECONOMIC-ASPECTS OF EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER

      Supportive care in cancer
    58. FELD R
      CRITERIA FOR RESPONSE IN PATIENTS IN CLINICAL-TRIALS OF EMPIRIC ANTIBIOTIC REGIMENS FOR FEBRILE NEUTROPENIA - IS THERE AGREEMENT

      Supportive care in cancer
    59. DEPAUW BE; MEIS JFGM
      PROGRESS IN FIGHTING SYSTEMIC FUNGAL-INFECTIONS IN HEMATOLOGICAL NEOPLASIA

      Supportive care in cancer
    60. Kuikka, A; Valtonen, VV
      Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    61. WANG FD; LIU YM; LIU CY
      BACTEREMIA IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Journal of the Formosan Medical Association
    62. WILSON APR
      COMPARATIVE SAFETY OF TEICOPLANIN AND VANCOMYCIN

      International journal of antimicrobial agents
    63. KALKUT G
      SULFONAMIDES AND TRIMETHOPRIM

      Cancer investigation
    64. HOLBROOK KA; LOWY FD
      BETA-LACTAM ANTIBIOTICS

      Cancer investigation
    65. ENGELS EA; LAU J; BARZA M
      EFFICACY OF QUINOLONE PROPHYLAXIS IN NEUTROPENIC CANCER-PATIENTS - A METAANALYSIS

      Journal of clinical oncology
    66. FISHMAN A; CHOWERS M; ALTARAS M; BEYTH Y; LANG R
      AZTREONAM PLUS PIPERACILLIN - EMPIRIC TREATMENT OF NEUTROPENIC FEVER IN GYNECOLOGY-ONCOLOGY PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY

      European journal of gynaecological oncology
    67. OPPENHEIM BA
      THE CHANGING PATTERN OF INFECTION IN NEUTROPENIC PATIENTS

      Journal of antimicrobial chemotherapy
    68. KLASTERSKY J
      SCIENCE AND PRAGMATISM IN THE TREATMENT AND PREVENTION OF NEUTROPENICINFECTION

      Journal of antimicrobial chemotherapy
    69. OKEREKE C; DUDLEY MN
      BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATIONS - PHARMACODYNAMIC CONSIDERATIONS AND POSSIBLE ROLE IN THE MANAGEMENT OF BACTERIAL-INFECTIONS IN THE NEUTROPENIC HOST/

      Journal of antimicrobial chemotherapy
    70. VISCOLI C
      THE EVOLUTION OF THE EMPIRICAL MANAGEMENT OF FEVER AND NEUTROPENIA INCANCER-PATIENTS

      Journal of antimicrobial chemotherapy
    71. Dompeling, EC; Donnelly, JP; Raemaekers, JMM; Deresinski, SC; Feld, R; De Pauw, BE
      Evolution of the clinical manifestations of infection during the course offebrile neutropenia in patients with malignancy

      INFECTION
    72. GUBBINS PO; BOWMAN JL; PENZAK SR
      ANTIFUNGAL PROPHYLAXIS TO PREVENT INVASIVE MYCOSES AMONG BONE-MARROW TRANSPLANTATION RECIPIENTS

      Pharmacotherapy
    73. Miranda-Novales, MG; Belmont-Martinez, L; Villasis-Keever, MA; Penagos-Paniagua, M; Bernaldez-Rios, R; Solorzano-Santos, F
      Empirical antimicrobial therapy in pediatric patients with neutropenia andfever. Risk factors for treatment failure

      ARCHIVES OF MEDICAL RESEARCH
    74. NAGATOMO A; WATANABE K; KUNIKANE H; OKAMOTO H; KUNITOH H
      A RANDOMIZED CONTROLLED TRIAL OF SULFAMETHOXAZOLE TRIMETHOPRIM PLUS NORFLOXACIN VERSUS SULFAMETHOXAZOLE/TRIMETHOPRIM ALONE FOR THE PROPHYLAXIS OF BACTERIAL-INFECTION DURING CHEMOTHERAPY FOR LUNG-CANCER/

      Lung cancer
    75. PTUSHKIN VV; BAGIROVA NS; VOLKOVA MA
      TREATMENT OF INFECTIONS IN PATIENTS WITH NEUTROPENIA

      Terapevticeskij arhiv
    76. LINDBLAD R; RODJER S; ADRIANSSON M; ANDREASSON B; BACKSTOM B; JOHANSSON P; KARLSSON K; RHEDIN C; TURESSON I
      EMPIRIC MONOTHERAPY FOR FEBRILE NEUTROPENIA - A RANDOMIZED STUDY COMPARING MEROPENEM WITH CEFTAZIDIME

      Scandinavian journal of infectious diseases
    77. VISCOLI C; CASTAGNOLA E; CANIGGIA M; DESIO L; GARAVENTA A; GIACCHINO M; INDOLFI P; IZZI GC; MANZONI P; ROSSI MR; SANTORO N; ZANAZZO GA; MASERA G
      ITALIAN GUIDELINES FOR THE MANAGEMENT OF INFECTIOUS COMPLICATIONS IN PEDIATRIC ONCOLOGY - EMPIRICAL ANTIMICROBIAL THERAPY OF FEBRILE NEUTROPENIA

      Oncology
    78. HERREROS JMC; GARCIAOTERO EC; GRANADO JC; CARRAL BB
      BACTEREMIA, ENDOCARDITIS AND MENINGITIS CAUSED BY PSEUDOMONAS-AERUGINOSA

      Revista Clinica Espanola
    79. MARTINEZ CJ; SANTASUSANA JMR; PEREZ MG; MASANA MB; LOPEZ AF; FERNANDEZAVILES F; CIA JMS; SANTOS FM; FRASNEDO EF
      PREVENTION AND TREATMENT OF INFECTIONS IN PATIENTS WITH NEUTROPENIA AND FEVER - THE ROLE OF PSEUDOMONAS-AERUGINOSA

      Revista Clinica Espanola
    80. KARTHAUS M; WOLF HH; KAMPFE D; EGERER G; RITTER J; PETERS G; SUDHOFF T; FRANKE A; HEIL G; KULLMANN KH; JURGENS H
      CEFTRIAXONE MONOTHERAPY IN THE TREATMENT OF LOW-RISK FEBRILE NEUTROPENIA

      Chemotherapy
    81. BIRON P; FUHRMANN C; ESCANDE MC; BLANCVINCENT MP; CROKAERT F; BEAL J; BUSSY V; LESIMPLE T; POTTECHER B; RAVENEAU J; SENET JM; VIOT M
      STANDARDS, OPTIONS AND RECOMMENDATIONS (SOR) FOR THE MANAGEMENT OF NEUTROPENIC CANCER-PATIENTS (EXCLUDING PROLONGED NEUTROPENIA)

      Bulletin du cancer
    82. GAYA H
      EMPIRICAL THERAPY OF INFECTIONS IN NEUTROPENIC PATIENTS

      British Journal of Haematology
    83. MAERTENS J; BOOGAERTS MA
      ANTIINFECTIVE STRATEGIES IN NEUTROPENIC PATIENTS

      Acta Clinica Belgica
    84. Schroder, CP; van der Graaf, WTA; Willemse, PHB; Vellenga, E; de Leij, L; Mulder, NH; de Vries, EGE
      The impact of haematopoietic growth factors on supportive care in clinicaloncology: With special attention to potential tumour cell contamination inthe stem cell harvest

      ALTERNATIVE APPROACHES TO HUMAN BLOOD RESOURCES IN CLINICAL PRACTICE
    85. VENDITTI M; MARTINO P
      THE IMPORTANCE OF IN-VITRO SUSCEPTIBILITY TESTING IN THE MANAGEMENT OF COMPROMISED HOSTS

      Journal of chemotherapy
    86. BODEY GP
      THE EVOLUTION OF ANTIBIOTIC-THERAPY FOR NEUTROPENIC PATIENTS

      Clinical cancer research
    87. CHANOCK SJ
      A REVIEW OF ANTIBACTERIAL AND ANTIFUNGAL THERAPY IN THE FEBRILE CHILDWITH NEUTROPENIA INDUCED BY ANTINEOPLASTIC THERAPY

      International journal of pediatric hematology/oncology
    88. HUGHES WT; ARMSTRONG D; BODEY GP; BROWN AE; EDWARDS JE; FELD R; PIZZO P; ROLSTON KVI; SHENEP JL; YOUNG LS
      1997 GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER

      Clinical infectious diseases
    89. HATHORN JW; LYKE K
      EMPIRICAL-TREATMENT OF FEBRILE NEUTROPENIA - EVOLUTION OF CURRENT THERAPEUTIC APPROACHES

      Clinical infectious diseases
    90. GOTZSCHE PC; JOHANSEN HK
      METAANALYSIS OF PROPHYLACTIC OR EMPIRICAL ANTIFUNGAL TREATMENT VERSUSPLACEBO OR NO TREATMENT IN PATIENTS WITH CANCER COMPLICATED BY NEUTROPENIA

      BMJ. British medical journal
    91. DEPAUW BE; RAEMAEKERS JMM; SCHATTENBERG T; DONNELLY JP
      EMPIRICAL AND SUBSEQUENT USE OF ANTIBACTERIAL AGENTS IN THE FEBRILE NEUTROPENIC PATIENT

      Journal of internal medicine
    92. BODEY GP
      THE TREATMENT OF FEBRILE NEUTROPENIA - FROM THE DARK-AGES TO THE PRESENT

      Supportive care in cancer
    93. KLASTERSKY J
      TREATMENT OF NEUTROPENIC INFECTION - TRENDS TOWARDS MONOTHERAPY

      Supportive care in cancer
    94. MASCHMEYER G; HIDDEMANN W; LINK H; CORNELY OA; BUCHHEIDT D; GLASS B; ADAM D
      MANAGEMENT OF INFECTIONS DURING INTENSIVE TREATMENT OF HEMATOLOGIC MALIGNANCIES

      Annals of hematology
    95. ERJAVEC Z; WOOLTHUIS GMH; DEVRIESHOSPERS HG; DAENEN SMGJ; DEPAUW B; HALIE MR
      TOLERANCE AND EFFICACY OF AMPHOTERICIN-B INHALATIONS FOR PREVENTION OF INVASIVE PULMONARY ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS

      European journal of clinical microbiology & infectious diseases
    96. CHARNAS R; LUTHI AR; RUCH W
      ONCE-DAILY CEFTRIAXONE PLUS AMIKACIN VS 3 TIMES DAILY CEFTAZIDIME PLUS AMIKACIN FOR TREATMENT OF FEBRILE NEUTROPENIC CHILDREN WITH CANCER

      The Pediatric infectious disease journal
    97. PATRICK CC
      USE OF FLUOROQUINOLONES AS PROPHYLACTIC AGENTS IN PATIENTS WITH NEUTROPENIA

      The Pediatric infectious disease journal
    98. DEPAUW BE; DONNELLY JP
      CONTROVERSIES IN THE ANTIBACTERIAL TREATMENT OF PATIENTS WITH NEUTROPENIA - A MATTER OF COMPREHENSION OR APPREHENSION

      Cancer investigation
    99. HIDDEMANN W; MASCHMEYER G; LINK H; HELMERKING M; ADAM D
      TREATMENT OF INFECTIONS IN ACUTE LEUKEMIA S

      Medizinische Klinik
    100. LORTHOLARY O; TOD M; DURANDGASSELIN B; GUILLEVIN L; PETITJEAN O; CASASSUS P
      USING GLYCOPEPTIDES IN FEBRILE NEUTROPENI C ADULTS

      Medecine et maladies infectieuses


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 18:21:48